Objective We examined rates of serious maternal complications in relation to severe pre-eclampsia based on the delivering hospital's annualised volume.
Introduction
Referral of high-risk patients to resource-intensive hospitals remains the cornerstone of best obstetrical practice. Studies have documented that regionalisation of care and timely referral of high-risk patients to large volume delivery hospitals (such as regional perinatal centres) is associated with lower rates of serious obstetrical and neonatal complications. [1] [2] [3] [4] [5] Lower risks of caesarean delivery 5 and birth asphyxia were observed among low delivery volume than among high delivery volume hospitals. In other studies, hospital delivery volume was not associated with adverse maternal complications in low-risk pregnancies 6, 7 and among certain high-risk pregnancies such as diabetes. 8 Whether hospital delivery volume is associated with serious maternal complications in the setting of severe pre-eclampsia remains unknown.
Severe pre-eclampsia is one of the chief causes of maternal deaths and serious obstetrical complications 9 and is implicated in 16% of maternal deaths in developed countries. 10 To date, no therapeutic or prophylactic interventions have proven successful for treating severe preeclampsia, with delivery of the placenta as the means of resolving the clinical symptoms. In fact, it has been reported that only about 80% of women with hypertension during pregnancy achieve resolution of blood pressures to normal levels within 6-7 weeks postpartum. 11 In the setting of mild pre-eclampsia, an expectant management strategy of 'wait and watch' for worsening disease is often adopted. [12] [13] [14] However, obstetrical management may also include expectant management for severe pre-eclampsia when diagnosed preterm; this approach balances potential fetal benefits of advancing gestational age with maternal risks for severe morbidity with disease progression; variation in care quality-associated hospital volume may be an important factor associated with maternal pre-eclampsia outcomes. It is therefore imperative to understand the extent to which maternal care quality for pre-eclampsia may be associated with obstetric volume.
We hypothesised that the risks of in-hospital maternal deaths and serious maternal complications associated with severe pre-eclampsia will be highest in low-volume delivery hospitals. The objectives of this study were to (i) assess rates of in-hospital maternal mortality, and serious maternal complications in relation to severe pre-eclampsia; (ii) quantify the burden of serious maternal complications in relation to severe pre-eclampsia; and (iii) examine the association between annualised hospital delivery volume and maternal mortality and serious maternal complications among women diagnosed with severe pre-eclampsia.
Methods

Premier data
We carried out a retrospective analysis based on the Perspective database (2006-2012) compiled by Premier, Inc. (Charlotte, NC, USA, www.premierinc.com). Perspective is a voluntary, fee-supported database developed to measure resource utilisation and quality of care. The Perspective database is the largest inpatient drug utilisation database in the USA. Perspective sampled a representative of acute-care hospitals between 2006 and 2012 throughout the USA that contributed data on all in-patient, out-patient and ambulatory hospital admissions. Institutional review board approval was sought as an exempt protocol, and approval was obtained from Columbia University Medical Center, NY. None of the authors was involved with patient participation.
Participants and cohort composition
All statistical analysis was weighted based on the sampling of the hospitals, provided in the data, to reflect national estimates. From a total of 28 504 661 (weighted) hospitalisations resulting in a delivery, we sequentially excluded the following: deliveries erroneously coded to males (weighted n = 1308), twins or higher order births (n = weighted n = 530 064), and maternal age <15 or >59 years (weighted n = 32 688). We then excluded deliveries at hospitals with an annualised volume <25 (n = 293 out-patient admissions), women with chronic or superimposed hypertension (weighted n = 2 117 737), and transfers in and out of hospitals (weighted n = 40 406).
Severe pre-eclampsia
All diagnostic and procedure codes are entered in the Perspective database based on the international classification of disease (ICD)-9 coding. In this study, we combined women with an ICD-9 indication of severe pre-eclampsia and eclampsia as a single entity called 'the syndrome of severe pre-eclampsia'. In a sub-analysis, we examined the rates of serious maternal complications separately for severe pre-eclampsia and eclampsia. We excluded women with diagnosis of chronic hypertension only, pre-eclampsia superimposed on chronic hypertension or gestational hypertension. Additionally, we excluded all transfers in and out of the delivery hospitalisation. The ICD codes for all the conditions examined are shown in Table S1 .
Primary and secondary outcomes
In-hospital maternal deaths prior to discharge from the delivery hospitalisation or severe medical complications were the primary end-points in this analysis. Severe complications that were examined included puerperal cerebrovascular disorders, pulmonary oedema, disseminated intravascular coagulation (DIC), and acute renal, heart and liver failure, sepsis and women who required intubation.
Covariates
We also examined the rates of severe pre-eclampsia in relation to patient, physician and hospital characteristics, stratified by hospital volume. Patient characteristics included year of delivery (2006-2012), maternal age (categorised by 5-year groups as <20, 20-24, 25-29, 30-34, 35-39, 40-44 and ≥45 years), maternal race (white, black, Hispanic and other races), single marital status, insurance status (commercial, Medicaid, Medicare or uninsured), and tobacco and alcohol use. Chronic medical conditions that were examined included chronic renal disease, asthma, congenital cardiac disease, and pregestational and gestational diabetes.
Provider-level covariates included physician specialty (general obstetrician-gynaecologist, maternal-fetal medicine specialist, family practice physician, midwife, or other) and provider volume of deliveries (categorised as low: 1-96 patients per year; intermediate: 97-166 patients per year; or high: >167 patients per year).
Hospital-level factors contained in the Perspectives database included region (Northwest, Midwest, West or South), hospital location (urban or rural), number of hospital beds (categorised as <200, 20-299, 300-399, 400-600 or >600), teaching hospital (yes or no), hospital's concentration of black patients and the proportion of Medicaid or uninsured patients (both categorised as <50%, 50-74%, 75-89% or ≥90%).
Statistical analysis
We first examined the distributions of maternal sociodemographic, provider, and hospital characteristics in relation to severe pre-eclampsia. Log-linear models with a random (hospital-specific) intercept to account for patients clustered within hospitals were fit to examine the difference in risk-adjusted rate of complications rates among severe pre-eclampsia and normotensive patients. From these models, we estimated risk ratios with 95% confidence intervals as the measure of effect.
A goal of this study is to examine the associations between severe pre-eclampsia and adverse outcomes based on annualised hospital delivery volume. We excluded hospitals with an annualised volume below 25, which was deemed necessary to avoid including women that may have delivered during an emergency room admission or at a critical access hospital. We categorised hospital volume as 25-500, 501-1000, 1001-2000 and >2000, with the cutoffs corresponding roughly to the four quartiles.
Finally, among women diagnosed with severe preeclampsia, we examined rates of severe maternal complications in relation to hospital volume. Volume was classified in deciles based on the hospital's risk-adjusted annual rate of severe pre-eclampsia. We derived the hospital-level rate of severe pre-eclampsia after adjusting for patient, physician and hospital characteristics. All analyses were based on hospital-specific random-intercept log-linear (Poisson) regression models, and associations were expressed as risk ratios (RR) and 95% confidence intervals.
Results
Following exclusions, the analytic cohort included 439 hospitals resulting in 25 782 235 weighted singleton deliveries between 2006 and 2012. The severe pre-eclampsia rate increased from 0.8% in low delivery volume hospitals (2-500) to 1.3% in high delivery volume hospitals (>2000). Young women (aged below 25 years), white women, single women, smokers and those on Medicaid or without any insurance delivered more commonly in low volume (25-500) hospitals (Table S2 ). Both provider and hospital characteristics were associated with hospital delivery volume. For instance, providers with low delivery volumes were more likely to deliver in low delivery volume hospitals. Women in the Northeast were more likely to deliver at low delivery volume hospitals, whereas women in the West were more likely to deliver in high volume hospitals. Women were more likely to deliver in high volume delivery hospitals in urban areas and hospitals affiliated with teaching status.
Rates of serious maternal complications among severe pre-eclampsia and normotensive women within strata of annualised hospital delivery volume are shown in Table 1 . Serious maternal complications were higher among women with severe pre-eclampsia than in normotensive women. The associations between severe pre-eclampsia and serious maternal complications following adjustment for patient, provider and hospital characteristics are shown in Table 2 . Compared with normotensive women, those with severe pre-eclampsia were at substantially increased rate of any serious complication (RR 8.7, 95% CI 7.6, 10.1), as well as all other maternal complications. Notably, the RRs for puerperal cerebrovascular disorders and pulmonary edema were even higher in women with severe pre-eclampsia, as were the RRs for acute renal and heart failure and intubation. Although maternal mortality rates were fairly consistent across hospital delivery volumes among normotensive women, among women with severe pre-eclampsia, the rate was substantially low in high compared with lower volume hospitals. No variation in RRs for composite of serious maternal complications was seen across hospital volume ( Figure 1) .
The rates of serious maternal complications were 410.7 per 10 000 to women who delivered in hospitals with a high rate of severe pre-eclampsia (>2.11%; reference) and 584.8 per 10 000 to women who delivered in hospitals with low severe pre-eclampsia rates (<0.42%; adjusted RR 1.75, 95% CI 1.24, 2.45) (Figure 2 ). This rate progressively declined as the hospital-specific severe pre-eclampsia rate increased, suggesting a dose-response association.
Sensitivity analyses
We performed additional sensitivity analysis to examine the associations between severe pre-eclampsia only and eclampsia on rates of serious maternal complications (Tables S3  and S4 ). These analyses for severe pre-eclampsia only were very similar to the overall analyses, but the associations between eclampsia and serious maternal complications were considerably stronger. However, no appreciable differences in associations were evident across annualised hospital delivery volumes (Figures S1 and S2 ).
Discussion
Main findings
Hypertensive disorders, especially pre-eclampsia and eclampsia, are one of the leading causes of maternal mortality in developed countries and are implicated in 16% of maternal deaths. 10, 15 Pre-eclampsia and eclampsia are also associated with excessively high rates of perinatal and infant mortality. 16, 17 Despite the abundance of data on preeclampsia and its impact on maternal mortality, few data exist on its association with severe maternal complications, 18, 19 and none, to the best of our knowledge, have examined the extent to which hospital delivery volume impacted these associations.
We show that severe pre-eclampsia is associated with over an eight-fold increased rate of serious maternal complications. With the exception of maternal deaths, contrary to our hypothesis, we did not observe much variability across annual hospital delivery volumes in the aforementioned associations. However, compared with hospitals with high severe pre-eclampsia rates, hospitals with low severe pre-eclampsia rates have higher rates of serious maternal complications; the rate of adverse outcomes diminished in hospitals based on increasing severe preeclampsia rates.
Limitations of the data
A few limitations of the study must be considered when interpreting the findings. Foremost among them is that a few covariates are unavailable in the Premier database (such as parity and body mass index at the patient-level). In addition, characteristics that reflect provider-level data are also unavailable, leaving room for the potential for unobserved confounding. Second, some of the serious maternal complications examined may be subject to some degree of misclassification. We are unable to speculate on the extent of misclassification (under-or over-reporting), nor the impact of such misclassification on the reported associations. Nonetheless, given the seriousness of the conditions and the prevalence estimates being in line with what have been reported in the literature, it is unlikely that these data are grossly under-coded. Thirdly, under-coding of secondary diagnoses not tied to reimbursements has been demonstrated to be a concern with administrative data analyses. As a result, secondary diagnoses may be underestimated in our models. 20 However, the Premier data undergo 95 distinct quality assurance and data validation checks before they are made available for research. This provides some reassurance regarding the validity of our findings. Fourthly, it is possible that our results are related to variation in coding for severe pre-eclampsia. That is, if cases of severe pre-eclampsia not related to a significant complication are systematically more or less likely to be coded administratively on a hospital-by-hospital basis, then hospitals coding more liberally for severe pre-eclampsia would be expected to have lower rates of severe morbidity relative to the number of patients with the diagnosis. Further research is indicated to determine whether our findings related to decreased rates of morbidity relative to the prevalence of diagnoses are due to actual better care or bias in diagnosis and coding. 
Strengths of the study
The large, population-based nature of the study allows generalisation of the findings. Importantly, we were able to adjust for a variety of patient, provider and hospital-level confounding factors through hierarchical log-linear regression models. Through this approach we were able to account for within-and between-hospital variability in severe pre-eclampsia and serious maternal complications. In addition, we were careful to examine only the most acute maternal complications; we purposefully avoided the including chronic conditions, as we were unsure about the temporal sequence of these chronic conditions with respect to the first occurrence of clinical symptoms of severe preeclampsia. Finally, we were able to examine the associations for patients with severe pre-eclampsia only from eclampsia through sensitivity analysis.
Clinical interpretation of findings
Regionalisation of care has been proposed as a means to reduce the burden and acuity of diseases. Such models of transfer of patients from low resource hospital settings to institutions with adequate resources to handle and treat such high-risk patients (regionalisation of care) have yielded compelling data. For instance, for cardiac patients transferred to high volume hospitals to undergo coronary artery bypass graft surgery have improved survival. 21 Similarly, findings are evident in other surgical specialties, including surgeries for prostatectomy 22 and colon cancer resection. 23 Based on a systematic review of studies in perinatal health, research has shown that regionalisation of perinatal services is associated with improved neonatal and infant survival. 24 Wright and colleagues 25 examined regionalisation of obstetrical care for postpartum haemorrhage and its impact on maternal deaths among women. They reported that maternal mortality rates in the USA were lower when peripartum hysterectomy for postpartum haemorrhage was performed in high volume hospital settings.
A recent joint statement by the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine 26 endorsed the need to establish regionalised maternal care for pregnant women at high risk to receive care in facilities that are prepared to provide the required level of specialised care. They opined that establishing such a framework for care regionalisation would help reduce the burden of maternal morbidity and mortality in the USA. Although this statement was intended to focus on the transfer of patients prior to developing a complication, our findings suggest that care quality for severe pre-eclampsia may vary, and that the prevalence of the diagnosis may be associated with less risk of severe morbidity.
An important issue for consideration is whether patients diagnosed with severe pre-eclampsia in hospitals with low resources should be transferred to hospitals with adequate physician, staffing and treatment resources. The progression from mild to severe pre-eclampsia in sick patients is often rapid, and we believe that transfer of the sick patients to resource-adequate centres with appropriate staffing experience may be beneficial. In addition, establishment of Figure 2 . Rate of serious maternal complications (per 10 000) among women with severe pre-eclampsia in hospitals classified based on risk-adjusted severe pre-eclampsia prevalence rates. Also shown are the adjusted risk ratio (95% confidence interval, shown on a logarithmic scale) of serious maternal complications in relation to hospital-classified deciles of severe pre-eclampsia risk (decile 10 is the referent category).
standardised clinical protocols for management of patients diagnosed with severe pre-eclampsia may help reduce the burden the maternal (and fetal) complications. In addition, our analyses reveal other important observations. The overall rates of disseminated intravascular coagulation and stroke were high, irrespective of hospital delivery volume categories. These findings underscore that establishing standardised protocols for the treatment of haemorrhage (for DIC) and hypertension (for stroke) also remain important. As well, the associations we report may have also been affected to some extent by our exclusion of inter-hospital transfers. This is more of an issue when small delivery volume hospitals transfer patients with serious complications to resource-adequate hospitals. Although we are unable to gauge the extent to which such transfers in and out of hospitals may have affected the overall conclusions, this issue must be considered when interpreting the data.
Arguably, all hospitals should be adequately prepared to handle the patients with complications related to severe pre-eclampsia, both hospital transfers and in-hospital resources. 27 Furthermore, research on maternal deaths has long been overlooked and despite attempts at policy change, 28, 29 the maternal mortality rate has been increasing in the USA. 30 In an effort to reduce the burden of maternal deaths in the state of New York, the 'Safe Motherhood Initiative' has recently introduced a severe hypertension bundle that provides a standardised treatment protocol for severe pre-eclampsia in an effort to guide obstetrical management of high-risk patients. 31 Given the increase in the prevalence rate of pre-eclampsia in developed countries, 32, 33 efforts to better understand and characterise the complex relationship among regionalisation of care, severe preeclampsia, and maternal outcomes is important.
Conclusions
We show that annualised hospital delivery volume has virtually no impact on the associations between severe preeclampsia and serious maternal complications. We believe that implementation of standardised treatment protocols for patients diagnosed with severe pre-eclampsia may help reduce the burden of untoward serious maternal complications.
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